Original Research

Chronic Kidney Disease and Anemia: Exploring Patterns with Creatinine Clearance <30 mL/min/1.73 m²

DOI https://doi.org/10.70302/jpsim.v6i2.2526
Received: 22 Jul 2024 Revised: 01 Jan 2025 Accepted: 24 Apr 2025 Published Online: 05 Jun 2025

Abstract

Objective

This study aims to determine the frequency and patterns of anemia in patients with chronic kidney disease (CKD) who have a creatinine clearance of less than 30 ml/min/1.73 m², in order to inform targeted treatment and reduce adverse outcomes.

Methods

This six-month prospective study at Fatima Memorial Hospital, Lahore, enrolled 156 CKD patients aged 18-60 with a creatinine clearance <30ml/min/1.73m², using nonprobability consecutive sampling. Exclusion criteria comprised of inflammatory diseases, recent blood loss, malignancy, or chemotherapy. Analysis via SPSS 22.0 had been done.

Results

The mean age of our study group was 47.2 ± 8.1years. The average age ranged between 38 and 45 years. Among these, 74.4% participants were males and 25.6% were females. All participants had anemia. The minimum mean hemoglobin level was 7g/dL and maximum were 11g/dL. 64.1% participants had normocytic normochromic anemia, 32.1% had iron deficiency anemia and 3.8% had combined deficiency anemia. These results confirmed the association of different patterns of anemia and CKD.

Conclusion

Present study highlights the prevalence and patterns of anemia in CKD patients with creatinine clearance below 30 ml/min/1.73m². Normocytic normochromic anemia was the most common pattern, followed by iron deficiency anemia and combined deficiency anemia. These findings underscore the multifactorial nature of anemia in CKD and its association with adverse outcomes such as cardiovascular complications and reduced quality of life.

Keywords
chronic kidney disease Iron deficiency anemia Normocytic normochromic Combined deficiency anemia

How to Cite This Article

Tanveer A, Rauf MK, Shahid F, Anwar S. Chronic Kidney Disease and Anemia: Exploring Patterns with Creatinine Clearance <30 mL/min/1.73 m². J Pak Soc Intern Med. 2025;6(2):136–140. doi:10.70302/jpsim.v6i2.2526

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266.
  2. World Health Organization technical report series No. 405: nutritional anemias – report of a WHO Scientific Group. Geneva: WHO; 1968.
  3. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989;35(1):134-48.
  4. Eckardt KU. Erythropoietin: oxygen-dependent control of erythropoiesis and its failure in renal disease. Nephron. 1994;67(1):7-23.
  5. Zadrazil J, Horak P. Pathophysiology of anemia in chronic kidney diseases: A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159(2):197-202.
  6. O'Mara NB. Anemia in patients with chronic kidney disease. Diabetes Spectr. 2008;21(1):12-9.
  7. Nalado AM, Mahlangu JN, Waziri B, Duarte R, Paget G, Olorunfemi G, Naicker S. Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa. Int J Nephrol Renovasc Dis. 2019; doi: 10.2147/IJNRD.S179802. doi:10.2147/IJNRD.S179802
  8. Ryu SR, Park SK, Jung JY, Kim YH, Oh YK, Yoo TH. The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD). J Korean Med Sci. 2017;32(2):249-56.
  9. Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med. 2002;162(12):1401-8.
  10. Miah OF, Hossain RM, Latif A, Sarkar U, Paul SK, Paul RS, Ahammod T, Islam MS, Dowel FA, Mahmud MA, Podder MK, Bhuiyan AS, Chowdhury UW. Pattern of Anaemia in Chronic Kidney Disease. Mymensingh Med J. 2019;28(1):1-7.
  11. Ullah K, Butt G, Masroor I, Kanwal K, Kifayat F. Epidemiology of chronic kidney disease in a Pakistani population. Saudi J Kidney Dis Transpl. 2015;26(6):1307-10.
  12. Dmitrieva O, de Lusignan S, Macdougall IC, Gallagher H, Tomson C, Harris K, et al. Association of anaemia in primary care patients with chronic kidney disease: cross sectional study of quality improvement in chronic kidney disease (QICKD) trial data. BMC Nephrol. 2013; doi: 10.1186/1471-2369-14-24. doi:10.1186/1471-2369-14-24
  13. Hasan M, Sutradhar I, Gupta RD, Sarker M. Prevalence of chronic kidney disease in South Asia: a systematic review. BMC Nephrol. 2018;19(1):291.
  14. Palaka E, Grandy S, van Haalen H, McEwan P, Darlington O. The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes-A Systematic Literature Review. Int J Nephrol. 2020; doi: 10.1155/2020/7692376. doi:10.1155/2020/7692376
  15. Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008; 35(2):329-44.
  16. Zhang QL, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health. 2008; doi: 10.1186/1471-2458-8-117. doi:10.1186/1471-2458-8-117
  17. Lv JC, Zhang LX. Prevalence and Disease Burden of Chronic Kidney Disease. Adv Exp Med Biol. 2019;doi: 10.1007/978-981-13-8871-2_1. doi:10.1007/978-981-13-8871-2_1
  18. Lewandowski MJ, Krenn S, Kurnikowski A, Bretschneider P, Sattler M, Schwaiger E, et al. Chronic kidney disease is more prevalent among women but more men than women are under nephrological care : Analysis from six outpatient clinics in Austria 2019. Wien Klin Wochenschr. 2023;135(3-4):89-96.
  19. Rai NK, Wang Z, Drawz PE, Connett J, Murphy DP. CKD Progression Risk and Subsequent Cause of Death: A Population-Based Cohort Study. Kidney Med. 2023;5(4):100604.
  20. Zoccali C, Mallamaci F, Adamczak M, de Oliveira RB, Massy ZA, Sarafidis P, et al. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovasc Res. 2023; 119(11):2017-32.
  21. van Haalen H, Jackson J, Spinowitz B, Milligan G, Moon R. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data. BMC Nephrol. 2020; 21(1):88.
  22. Vos FE, Schollum JB, Coulter CV, Doyle TC, Duffull SB, Walker RJ. Red blood cell survival in long-term dialysis patients. Am J Kidney Dis. 2011; 58(4):591-8.
  23. United States Renal Data System. CKD in the General Population. 2023 Annual Report. Available from: [https://adr.usrds.org/2020/chronic-kidney-disease/1-ckd-in-the-general-populationInternet ].
  24. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986;2(8517):1175-8.
  25. Hanna RM, Streja E, Kalantar-Zadeh K. Burden of Anemia in Chronic Kidney Disease: Beyond Erythropoietin. Adv Ther. 2021;38(1):52-75. =
  26. Shaikh H, Hashmi MF, Aeddula NR. Anemia of Chronic Renal Disease. In: StatPearls. [updated 2023 Feb 24] Available from: [ https://www.ncbi.nlm.nih.gov/books/NBK539871/ ].
  27. Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019; 133(1):40-50.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2025 Journal of Pakistan Society of Internal Medicine.